Plasma Cell-free RNA Signatures of Inflammatory Syndromes in Children

Insights

Pediatric inflammatory syndromes like Kawasaki disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) can now be diagnosed using circulating cell-free RNA (cfRNA) in plasma, improving accuracy and identifying organ damage.

Area of Science:

  • Biomarkers
  • Molecular Diagnostics
  • Pediatric Medicine

Background:

  • Inflammatory syndromes are common pediatric hospital admissions, often misdiagnosed due to limited molecular diagnostic tools.
  • Accurate differential diagnosis of conditions like Kawasaki disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) is challenging due to overlapping symptoms.

Approach:

  • Circulating cell-free RNA (cfRNA) in plasma was profiled from 370 pediatric patients with inflammatory conditions.
  • Machine learning models were developed using cfRNA profiles to differentiate between KD, MIS-C, viral, and bacterial infections.
  • The study explored cfRNA's utility in characterizing tissue and organ-specific injury.

Key Points:

  • Machine learning models achieved high performance (AUC = 0.97) in differentiating KD from MIS-C.
  • A multiclass model accurately distinguished between KD, MIS-C, viral, and bacterial infections with 81% accuracy.
  • cfRNA profiles effectively quantified injury to organs including the liver, heart, endothelium, nervous system, and respiratory tract.

Conclusions:

  • Circulating cell-free RNA (cfRNA) is a versatile analyte for diagnosing and characterizing pediatric inflammatory syndromes.
  • This approach offers a promising molecular tool to improve diagnostic accuracy and patient management for children with inflammatory conditions.